{
    "id": 31258,
    "fullName": "APC L852*",
    "impact": "nonsense",
    "proteinEffect": "loss of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "APC L852* results in a premature truncation of the Apc protein at amino acid 852 of 2843 (UniProt.org). L852* has not been characterized, however, Apc truncation mutants downstream of L852 are inactivating (PMID: 18199528) and therefore, is predicted to lead to a loss of Apc protein function.",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 2395,
                    "pubMedId": 18199528,
                    "title": "Multiple rare nonsynonymous variants in the adenomatous polyposis coli gene predispose to colorectal adenomas.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/18199528"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 324,
        "geneSymbol": "APC",
        "terms": [
            "APC",
            "BTPS2",
            "DESMD",
            "DP2",
            "DP2.5",
            "DP3",
            "GS",
            "PPP1R46"
        ]
    },
    "variant": "L852*",
    "createDate": "10/11/2019",
    "updateDate": "10/11/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 18750,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, G007-LK treatment did not alter gene expression pattern or affect growth in intestinal organoids established from mouse models of colorectal cancer driven by APC L850* (corresponding to L852* in human), and had no effect on tumor cell growth and differentiation in APC L850* mouse models (PMID: 31337618).",
            "molecularProfile": {
                "id": 33599,
                "profileName": "APC L852*"
            },
            "therapy": {
                "id": 2991,
                "therapyName": "G007-LK",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 16445,
                    "pubMedId": 31337618,
                    "title": "Distinct Colorectal Cancer-Associated APC Mutations Dictate Response to Tankyrase Inhibition.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31337618"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 33599,
            "profileName": "APC L852*",
            "profileTreatmentApproaches": [
                {
                    "id": 19734,
                    "name": "CTNNB1 Inhibitor",
                    "profileName": "APC L852*"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}